Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder

Vincent Sauzeau, Julien Beignet, Christian Bailly

Open source

DOI
10.3390/biomedicines10061357
Published
2022-06-08
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines10061357,
  title = {Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder},
  author = {Vincent Sauzeau and Julien Beignet and Christian Bailly},
  year = {2022},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines10061357},
  url = {https://doi.org/10.3390/biomedicines10061357}
}

RIS

TY  - JOUR
TI  - Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder
AU  - Vincent Sauzeau
AU  - Julien Beignet
AU  - Christian Bailly
PY  - 2022
JO  - Biomedicines
DO  - 10.3390/biomedicines10061357
UR  - https://doi.org/10.3390/biomedicines10061357
ER  - 

APA

Sauzeau, V., Beignet, J., & Bailly, C. (2022). Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder. Biomedicines. https://doi.org/10.3390/biomedicines10061357

Source records